Medical/Pharmaceuticals
PeproMene Bio, Inc. Announced Complete Response of The First Patient Treated in Its B-cell Non-Hodgkin Lymphoma (B-NHL) Phase 1 Clinical Trial of PMB-CT01 (BAFFR-CAR T Cells) at City of Hope
IRVINE, Calif., Dec. 21, 2022 /PRNewswire/ -- PeproMene Bio, Inc., a clinical-stage biotech company developing novel therapies to treat cancers and immune disorders, today announced that the first patient treated in its phase 1 relapsed or refractory B-cell Non-Hodgkin Lymphoma (r/r B-NHL) clinic...
2022-12-21 09:00
1991
Ascletis' NASH Drug ASC41(THRβ) Phase II Enrollment is Progressing as Planned
HANGZHOU and SHAOXING, China, Dec. 21, 2022 /PRNewswire/ -- The enrollment of the 52-week Phase II clinical trial of thyroid hormone receptor β (THRβ) agonist ASC41 developed in house by Gannex Pharma Co., Ltd., a wholly owned subsidiary of Ascletis Pharma Inc. (HKEX: 1672, "Ascletis"), for tr...
2022-12-21 08:00
2339
Sirnaomics Announces Interim Data from Phase I Clinical Trial of RNAi Therapeutic STP707 for Treatment of Multiple Solid Tumors
First three out of five cohorts pass safety requirements, allowing the Company to dose additional cohorts to assess safety, tolerability, pharmacokinetics and anti-tumor activity HONG KONG, GERMANTOWN, Md., and SUZHOU, China, Dec. 21, 2022 /PRNewswire/ -- Sirnaomics Ltd.(Stock Code: 2257.HK) (th...
2022-12-21 00:39
2981
Sanisure Announces the Acquisition of a Leading Silicone Extrusion Facility in Twinsburg, Ohio
CAMARILLO, Calif., Dec. 21, 2022 /PRNewswire/ -- Sanisure, a leading, vertically-integrated player in the single- use bioprocessing technology space, is pleased to announce the acquisition of Medical Elastomer Development, Inc ("MED") a silicone extrusion facility from Q Holding, a 3i portfolio c...
2022-12-21 00:06
2120
AstraZenca, G42 Healthcare enter strategic partnership to manufacture pharmaceutical products in Abu Dhabi
ABU DHABI, UAE, Dec. 20, 2022 /PRNewswire/ -- Building on the ongoing efforts of the Department of Health –Abu Dhabi (DoH) in spearheading Abu Dhabi's healthcare ecosystem, AstraZeneca, a science-led biopharmaceutical and one of the top 10 biopharma companies globally, and G42 Healthcare, an AI-p...
2022-12-20 23:16
2360
Kira Pharmaceuticals Announces Clearance to Initiate Phase 2 Evaluation of KP104 in IgA Nephropathy (IgAN) and Complement 3 Glomerulopathy (C3G) in China and Australia
CAMBRIDGE, Mass., Dec. 20, 2022 /PRNewswire/ -- Kira Pharmaceuticals, a global biotechnology company pioneering transformational complement therapies to treat immune-mediated diseases, announced today that the Chinese National Medical Products Administration (NMPA) and the Australian Therapeutic ...
2022-12-20 20:00
2183
Mentice AB (publ) receives an order of 1,1 million USD for simulation solutions from Beijing Huanya Zhitong on behalf of the Chinese Medical Education Association.
GOTHENBURG, Sweden, Dec. 20, 2022 /PRNewswire/ -- Mentice AB (publ), Gothenburg , a world leader in simulation solutions for image-guided interventional therapies, announced today that Beijing Huanya Zhitong,Beijing, China, has signed an agreement to acquire Mentice VIST® simulation solutions for ...
2022-12-20 00:35
1500
Carrick Therapeutics and The Menarini Group Announce Clinical Trial Collaboration to Evaluate Samuraciclib and Elacestrant Combination
Carrick to execute Phase 2 clinical trial in patients with CDK4/6i resistant HR+, HER2- metastatic breast cancer DUBLIN and FLORENCE, Italy, Dec. 19, 2022 /PRNewswire/ -- Carrick Therapeutics, an oncology-focused biopharmaceutical company discovering and developing highly differentiated therapie...
2022-12-19 23:07
1891
Carcell welcomes Prof. Harvey Lodish as Chair of its Scientific Advisory Board
SINGAPORE and SHANGHAI, Dec. 19, 2022 /PRNewswire/ -- Carcell Biopharma
2022-12-19 22:00
1786
Health and Hydrogen launches one of the first medical-grade Molecular Hydrogen Inhalation Machine HAH-301
GURGAON, India, Dec. 19, 2022 /PRNewswire/ -- Molecular Hydrogen Inhalation
therapy is now extensively used for its many health benefits, such as reducing
inflammation, improving cellular function, and protecting against oxidative
stress.Health And Hydrogen
2022-12-19 21:01
2052
China and ASEAN Deepened Exchanges and Cooperation on Traditional Medicine
BEIJING, Dec. 19, 2022 /PRNewswire/ -- A report from CRIOnline: From December 11 to 13, the 7th China-ASEAN Forum on Traditional Medicine was held in Fangchenggang City,Guangxi, China. China-ASEAN Forum on Traditional Medicine is held every two years. With the theme of "Seizing RCEP Opportunitie...
2022-12-19 20:01
2047
Ascletis Announces Notice of Issuance of the U.S. Patent for Oral Viral Polymerase Inhibitor ASC10 and Its Derivatives
--The issue date of the patent will be January 3, 2023 by the United States Patent and Trademark Office (USPTO). The patent number is 11,541,071 -- The issued patent covers ASC10 and its derivatives, and their uses to treat virus infections including SARS-CoV-2, monkeypox virus and respiratory s...
2022-12-19 18:10
1869
Magnetic Resonance Imaging Market to Witness Growth Due to The Increasing Demand for Scans
The prevalence of cardiovascular and oncology diseases and the shortage of radiologists have boosted the development of innovative MRI technologies SAN ANTONIO, Dec. 19, 2022 /PRNewswire/ -- The traditional magnetic resonance imaging (MRI) approach is being disrupted by portable MRI systems, open...
2022-12-19 16:12
1525
SmartFuture Launches First Responder Platform
SINGAPORE, Dec. 19, 2022 /PRNewswire/ -- As a key addition to its portfolio of Remote Patient Monitoring (RPM) solutions, SmartFuture has launched a First Responder Platform. This is an integrated solution designed for rapid response through real time monitoring of health vitals, doctor consultat...
2022-12-19 16:09
1591
Clinical Trial Approval For The Company's Novel Adjuvanted Recombinant Shingles Vaccine REC610 In The Philippines
TAIZHOU, China, Dec. 19, 2022 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (the "Company", together with its subsidiaries, the "Group") is pleased to announce that, the Group has recently received the clinical trial approval for its novel adjuvanted recombinant shingles vaccine, REC610, fr...
2022-12-19 13:53
2144
'NCDs in Focus Act Now' Summit organized by Viatris
The summit aimed to build synergies between healthcare professions and policy makers, addressing the challenges in the management of NCDs inSoutheast Asia BANGKOK, Dec. 19, 2022 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS): The 'NCDs in Focus Act Now' Summit was recently organised by global health...
2022-12-19 09:30
1912
Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology
* Acquisition to bring germline and somatic testing, cell-free DNA-based (liquid biopsy), and tissue-genomic profiling onto a single platform * Cancer genomics testing is now standard practice for cancer care and has shown to be highly successful such as Foundation One (acquired by Roche), Gra...
2022-12-16 19:56
3092
Possible Breakthrough in Cardiovascular Disease Diagnostics for Southeast Asia
SINGAPORE, Dec. 16, 2022 /PRNewswire/ -- Neuome Peptides Pte. Ltd., a Singapore
-based company has established an assay-developmentplatform, powered by machine
learning and novel, patented algorithms for the quantifiable detection of
biomarkers.
2022-12-16 16:03
2332
CES 2023: OMRON Healthcare Introducing Initiatives to Advance Its Vision of "Going for Zero" -- Elimination of Heart Attack and Stroke
KYOTO, Japan, Dec. 16, 2022 /PRNewswire/ -- OMRON Healthcare Co., Ltd. (hereinafter the Company) will exhibit at CES 2023 (*), the world's largest consumer tech show taking place inLas Vegas from Thursday, January 5, through Sunday, January 8. At the show, the Company will showcase the innovative...
2022-12-16 16:00
2790
Novavax Announces Pricing of $65 Million Public Offering of Common Stock
GAITHERSBURG, Md., Dec. 16, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced the pricing of an underwritten public offering to sell 6,500,000 shares of ...
2022-12-16 14:49
4576
Week's Top Stories
Most Reposted
Multiple achievements made in China-Hungary BRI conference
[Picked up by 319 media titles]
2024-05-03 06:59
Shanghai Jiao Tong University Offers Free Online Courses for International Learners, Joint Programs with Tmall of Alibaba and Dow Gain High Popularity
[Picked up by 314 media titles]
2024-05-07 08:00
Xinhua president, Hungarian economy minister vow to bolster media cooperation
[Picked up by 289 media titles]
2024-05-03 06:25TAILG Makes Grand Appearance at 2024 Asiabike Jakarta, Aiming to Set the Benchmark in Indonesia
[Picked up by 262 media titles]
2024-05-02 01:21
China-Serbia forum highlights community with shared future for mankind
[Picked up by 245 media titles]
2024-05-01 11:39
Most Read
/C O R R E C T I O N -- Addverb/
2024-05-03 20:26
12290
Multiple achievements made in China-Hungary BRI conference
2024-05-03 06:59
8529
Xinhua president, Hungarian economy minister vow to bolster media cooperation
2024-05-03 06:25
8064
